RGI has developed several in vitro assays that allow investigators to quickly screen potential compounds for anti-cancer efficacy. This allows researchers to determine which novel anti-cancer therapies may be most effective and determine in which direction further research should be pursued. We now offer wide range of assays for use by other investigators who wish to use our efficient and accurate systems to compliment their drug development and discovery efforts. RGI uses several methodologies which can be customized to meet your particular needs. We have many different cell lines representing most tissue types that can be used for screening anti-cancer drugs. RGI can investigate drug effects on many different cancers cells simultaneously and also conduct mechanistic studies. Some of these are proprietary. We can obtain special cell lines that are of interest to investigators when they have particular requirements. The data are provided in a comprehensive and easily interpreted format.